Omeros Corp. (OMER)

8.83 +0.06 (+0.74%) USD  |  NASDAQ  |  Dec 17, 16:00
8.92 +0.09 (+1.02%) After-Hours: 20:00
More

Omeros Research and Development Expense (Annual): 119.52M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for OMER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Johnson & Johnson 17.26B
Eli Lilly & Co. 10.99B
GeoVax Labs, Inc. 23.71M
Vistagen Therapeutics, Inc. 39.38M
Daré Bioscience, Inc. 14.21M